Related Experiment Video

Updated: Apr 26, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K

Design, implementation, and evaluation of a pediatric and adolescent type 2 diabetes management program at a tertiary

M Constantine Samaan1, Marlie Valencia2, Connie Cheung2

  • 1Department of Pediatrics, McMaster University, Hamilton, ON, Canada ; Division of Pediatric Endocrinology, McMaster University, Hamilton, ON, Canada ; Children's Exercise and Nutrition Center, McMaster University, Hamilton, ON, Canada.

Journal of Multidisciplinary Healthcare
|August 13, 2014
PubMed

Insights

A new multidisciplinary program improved type 2 diabetes management in youth, significantly lowering glycated hemoglobin and stabilizing BMI. This family-centered approach addresses the growing challenge of pediatric type 2 diabetes.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Global incidence of type 2 diabetes in children and adolescents has risen sharply in recent decades.
  • Type 2 diabetes in pediatric populations is a relatively new phenomenon, with limited established treatment program structures.
  • Effective management strategies for pediatric type 2 diabetes comorbidities and complications are urgently needed.

Purpose of the Study:

  • To describe the design and implementation of a personalized, multidisciplinary, family-centered program for pediatric and adolescent type 2 diabetes.
  • To evaluate the program's impact on key clinical and metabolic markers in young patients.

Main Methods:

  • Implementation of a personalized, multidisciplinary, family-centered care model at a tertiary pediatric center.
  • Longitudinal assessment of patient outcomes including glycated hemoglobin, body mass index, C-peptide, and metabolic biomarkers.

Main Results:

  • Significant improvement in glycated hemoglobin levels (8% to 6.4% at 1 year, P < 0.0001).
  • Stabilization of body mass index and reduction in C-peptide levels observed.
  • No significant changes noted in fitness or metabolic biomarkers for lipid metabolism and liver function.

Conclusions:

  • A multidisciplinary, family-centered approach is effective in managing type 2 diabetes in pediatric and adolescent populations.
  • This program model shows promise in addressing the complexities of youth-onset type 2 diabetes and mitigating adverse outcomes.
  • The findings underscore the need for specialized programs to combat the increasing prevalence of type 2 diabetes in young people.

Keywords:
adolescentsmultidisciplinarypediatricprogram designtype 2 diabetes

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
11
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
8
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K